Results 91 to 100 of about 14,748 (188)

Midterm Efficacy of SubcutAneous Implantable CardioVErter‐Defibrillator in ≤ 18 Year‐Old CHILDREN (SAVE CHILDREN‐II Registry)

Journal of Arrhythmia, Volume 42, Issue 4, August 2026.
S‐ICD therapy demonstrated favorable mid‐term safety and efficacy in pediatric patients, with durable sensing performance and a low incidence of device‐related infection. ABSTRACT Background The subcutaneous implantable cardioverter‐defibrillator (S‐ICD) avoids transvenous leads and is a promising option for sudden cardiac death (SCD) prevention in ...
Hitoshi Mori, Taisuke Nabeshima, Kota Nagaoka, Hideo Fukunaga, Hidemori Hayashi, Osamu Inaba, Yuhei Isonaga, So Asano, Junichi Nitta, Shigeo Watanabe, Sou Otsuki, Hiroshi Suzuki, Hidehira Fukaya, Jun Kishihara, Toshiyuki Chisaka, Takashi Higaki, Ayako Okada, Hideki Kobayashi, Takayuki Sekihara, Takafumi Oka, Seiichi Sato, Keisuke Yoshino, Hidekazu Kondo, Naohiko Takahashi, Ken Kato, Masaru Miura, Jun Maeda, Shuntaro Tamura, Kentaro Ikeda, Hiroko Goto, Takashi Murakami, Tsutomu Wada, Motoki Takamuro, Tsugutoshi Suzuki, Yuji Ishida, Shingo Sasaki, Takuro Nishimura, Masateru Takigawa, Tomomi Matsuura, Tomohiko Imamura, Satoshi Shizuta, Masato Fukunaga, Maiko Kuroda, Rintaro Hojo, Seiji Fukamizu, Hirohiko Suzuki, Yukihiko Yoshida, Itsuro Morishima, Kenji Kuraishi, Eiki Nishihara, Yoshihisa Naruse, Tomoyuki Sato, Yoshiyasu Aizawa, Kimitaka Nishizaki, Kentaro Nakamura, Norihito Nuruki, Masao Yoshinaga, Yukitoshi Ikeya, Yasuo Okumura, Shota Muraji, Yusuke Kondo, Makoto Nakano, Machiko Kito, Yasuya Inden, Satoshi Higuchi, Takahiko Kinjo, Kazuhisa Matsumoto, Masataka Narita, Wataru Sasaki, Tsukasa Naganuma, Daisuke Kawano, Naomichi Tanaka, Kei Matsumoto, Takuro Kojima, Yoshifumi Ikeda, Ritsushi Kato, Naokata Sumitomo   +76 more
wiley   +1 more source

Case Report: Contrasting phenotypes of arrhythmogenic cardiomyopathy: classic desmosomal ARVC and a RIT1-related phenocopy

Frontiers in Cardiovascular Medicine
BackgroundArrhythmogenic right ventricular cardiomyopathy (ARVC) is most commonly associated with pathogenic variants in desmosomal genes. However, ARVC-like phenotypes may also arise from non-desmosomal genetic backgrounds, creating diagnostic ...
Bo Eun Park, Bo Eun Park, Dong Heon Yang, Dong Heon Yang   +3 more
doaj   +1 more source

Electrocardiographic Predictors of Cardiac Reverse Remodeling After Left Bundle Branch Area Pacing in Atrioventricular Block: Emphasis on Post‐Pacing QRS Duration

Journal of Arrhythmia, Volume 42, Issue 4, August 2026.
In patients with atrioventricular block undergoing left bundle branch area pacing, shorter post‐pacing QRS duration was associated with cardiac reverse remodeling. Post‐pacing QRS duration may represent a simple and clinically applicable electrocardiographic marker for identifying patients more likely to achieve reverse remodeling.
Fahmi Nur Hidayatullah, Giky Karwiky, Mohammad Rizki Akbar, Mohammad Iqbal, Vanny Febriana, Chaerul Achmad   +5 more
wiley   +1 more source

Obstructive Sleep Apnea: Epidemiology, Pathophysiology, Complications, Diagnosis, Management, and Emerging Fibrosis‐Linked Remodeling

MedComm, Volume 7, Issue 8, August 2026.
Obstructive sleep apnea (OSA) is characterized by recurrent upper‐airway collapse, which generates key nocturnal stressors including intermittent hypoxia, sleep fragmentation, intrathoracic pressure stress, and sympathetic activation. These physiological disturbances converge on shared biological mechanisms, including oxidative stress, inflammation ...
Nhi Ho Thi Thuy, Thị Hằng Giang Phan, Ali Hussein Eid, Paola Maccioccu, Stefania Camboni, Gavino Casu, Anna Maria Posadino, Roberta Giordo, Gianfranco Pintus   +8 more
wiley   +1 more source

Arrhythmogenic Right Ventricular Cardiomyopathy Diagnosed with 2020 International Criteria

Journal of the Indian Academy of Echocardiography & Cardiovascular Imaging
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a rare cardiomyopathy. Early diagnosis is important to prevent mortality. They have a high risk of sudden cardiac death due to ventricular arrhythmia, which requires the implantation of a ...
Neelesh Damor, Nitin Modi, Atul Karande, Ashish Mishra, Sunil Sharma   +4 more
doaj   +1 more source

Genetic Bases of Arrhythmogenic Right Ventricular Cardiomyopathy

Heart International, 2006
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a heart muscle disease in which the pathological substrate is a fibro-fatty replacement of the right ventricular myocardium. The major clinical features are different types of arrhythmias with a left branch block pattern.
openaire   +5 more sources

Management of arrhythmogenic right ventricular cardiomyopathy.

Minerva medica, 2016
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a genetically determined heart muscle disorder, predisposing to sudden cardiac death (SCD), particularly in young patients and athletes. Pathological features include loss of myocytes and fibrofatty replacement of right ventricular myocardium; a biventricular involvement is often observed.
Silvano, Maria, Mastella, Giulio, Zorzi, Alessandro, MIGLIORE, FEDERICO, PILICHOU, KALLIOPI, BAUCE, BARBARA, Rigato, Ilaria, PERAZZOLO MARRA, MARTINA, ILICETO, SABINO, THIENE, GAETANO, BASSO, CRISTINA, CORRADO, DOMENICO, SILVANO, MARIA   +12 more
openaire   +2 more sources

Voltage mapping and right ventriculography to guide ablation for arrhythmogenic right ventricular cardiomyopathy ventricular tachycardia: a case report

Journal of Cardiothoracic Surgery
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a family inherited cardiomyopathy associated with ventricular arrhythmias. With the development of molecular biology, histology, imaging, and other diagnostic techniques, the diagnosis rate and ...
Chengying Yang, Yihua Cai, Yan Wei, Gang Li, Xinrong Fan   +4 more
doaj   +1 more source

Role of Catheter Ablation in Arrhythmogenic Right Ventricular Dysplasia

Indian Pacing and Electrophysiology Journal, 2005
Arrhythmogenic right ventricular dysplasia/cardiomyopathy is a disorder characterized by frequent ventricular tachycardia originating from the right ventricle and fibro-fatty replacement of right ventricular myocardium. Though the disorder was originally
Guy Fontaine, Johnson Francis
doaj  

Clinical value of anti-desmoglein-2 antibodies in arrhythmogenic right ventricular cardiomyopathy: real-world evidence. [PDF]

Europace
Joseph S, Borowiec K, Woźniak O, Chatterjee D, Fatah M, Silbiger V, Kowalik I, Skrzypczyńska-Banasik U, Kowalik E, Kowalski M, Biernacka EK, Hamilton RM.   +11 more
europepmc   +1 more source